41 %Among patients with type 1 diabetes (T1D), 41.0% cited impact on social life as a reason for insulin discontinuation.
Cameroundiabète de type 1observed 2016-2017published 2021Advances in therapyeurope_pmcdocument of 12 observations
Gold tier: mechanically validated evidence, with its primary source.
1,754 evidence items · page 67 / 71
41 %Among patients with type 1 diabetes (T1D), 41.0% cited impact on social life as a reason for insulin discontinuation.
Cameroundiabète de type 1observed 2016-2017published 2021Advances in therapyeurope_pmcdocument of 12 observations
1.3 %HIV prevalence in the general population of the Democratic Republic of Congo was 1.3%.
CamerounVIH/sidapublished 2015International journal of STD & AIDSeurope_pmcdocument of 6 observations
13.8 %Morganella morganii accounted for 13.8% of isolated germs.
Camerounpied diabétiquepublished 2022The Pan African medical journaleurope_pmcdocument of 25 observations
54 %54% (20/37) of Plasmodium malariae infections in Mfou were mixed P. falciparum/P. malariae infections.
CamerounpaludismeHAL · Unilimdocument of 106 observations
33.7 %The age-standardized control rate for diabetes alone was 33.7% among women in a semi-urban population in Bafoussam, Cameroon.
Cameroundiabète (non précisé)observed 2012published 2014BMC public healtheurope_pmcdocument of 24 observationsDOI 10.1186/1471-2458-14-696
91 %Ninety-one percent of the participants had type 2 diabetes.
Cameroundiabète de type 2published 2007Diabetes research and clinical practiceeurope_pmcdocument of 5 observations
More than half of the households visited had at least one individual infected with Plasmodium parasites.
Camerounpaludismepublished 2021The Journal of infectious diseaseseurope_pmcdocument of 4 observationsDOI 10.1093/infdis/jiaa774
65 patients65 patients with sickle cell disease were potentially exposed to a total of ten undesirable RH antigens.
CameroundrépanocytoseHAL · Unilimdocument of 45 observations
35 mgAlbuminuria after exercise had a median of 35 mg and interquartile range of 23–80 mg in non-hypertensive type 2 diabetes patients.
Cameroundiabète de type 2published 2017World journal of nephrologyeurope_pmcdocument of 7 observations
27 %The percentage of the diabetic population who had ever been told that they had diabetes had a median of 27%.
Cameroundiabète (non précisé)observed 2005-15published 2016The lancet. Diabetes & endocrinologyeurope_pmcdocument of 10 observations
1.9 odds_ratioThere was an association between diabetes and cardiovascular diseases (OR 1.9 [95% CI: 0.8–4.9]).
Cameroundiabète (non précisé) · maladies cardiovasculairespublished 2017BMC health services researcheurope_pmcdocument of 7 observationsDOI 10.1186/s12913-017-2197-0
Co-treatment with Octreotide and Pegvisomant resulted in unchanged tumor size as measured by MRI in a 36 year-old male patient with a somatotropin and thyreotropin secreting pituitary adenoma.
Camerounsomatotropin and thyreotropin secreting pituitary adenomapublished 2006Annales d'endocrinologieeurope_pmcdocument of 3 observations
34 %According to the 2019 annual report of the NMCP, malaria prevalence in the Adamawa region was 34%.
Camerounpaludismeobserved 2019HAL · Unilimdocument of 106 observations
17,400,000 DALYsIn 2017, breast cancer caused 17.4 million DALYs in women.
Camerouncancer du seinobserved 2017published 2019JAMA oncologyeurope_pmcdocument of 25 observationsDOI 10.1001/jamaoncol.2019.2996
5 hospitalisations_par_moisAu Cameroun, la fréquence des hospitalisations pour drépanocytose est estimée à entre 5 et 7 par mois chez les adolescents.
CameroundrépanocytoseHAL · Unilimdocument of 75 observations
3.4 %58 patients (3.4%) in the hospital group had no follow-up visit.
CamerounVIH/sidapublished 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations
422,700,000 casesIn 2015, there were an estimated 422.7 million cases of cardiovascular disease.
Camerounmaladies cardiovasculairesobserved 2015published 2017Journal of the American College of Cardiologyeurope_pmcdocument of 2 observations
26.1 %Age-standardised rates of death from neurological disorders decreased by 26.1% between 1990 and 2015.
Camerounneurological disordersobserved 1990–2015published 2017The Lancet. Neurologyeurope_pmcdocument of 10 observations
97 %In 2017, the majority of cancer DALYs came from years of life lost (97%).
Camerouncancer (non précisé)observed 2017published 2019JAMA oncologyeurope_pmcdocument of 25 observationsDOI 10.1001/jamaoncol.2019.2996
13.04 %Men had a PCR-positivity rate of 13.04%.
CamerounCOVID-19observed November 2020 to July 2021published 2023VirusesOpenAlexdocument of 12 observationsDOI 10.3390/v15020407
68.5 %Among those testing HIV-positive, 68.5% (403) received CD4 testing.
CamerounVIH/sidapublished 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations
Cameroon reported mpox cases belonging to both Clade I and Clade II.
CamerounClade I · Clade II · mpoxAfrica CDCdocument of 11 observations
45 %Population attributable risk indicated that up to 45% of stroke mortality could be reduced by appropriate detection and treatment of high blood pressure.
Camerounhypertension artériellepublished 2001Journal of hypertensioneurope_pmcdocument of 7 observationsDOI 10.1097/00004872-200101000-00006
2 samplesTwo plasma samples (one from a chimpanzee and one from a baboon) were positive for PARV4 by PCR.
CamerounPARV4published 2010Journal of VirologyOpenAlexdocument of 10 observations
45 per_100000The median annual incidence of epilepsy in high-income countries is estimated at 45.0 per 100,000.
CamerounépilepsieHAL · Unilimdocument of 53 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.